Back
Usana Health Sciences Quote, Financials, Valuation and Earnings
Sponsored
USNA
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Buy
52
USNA
Usana Health Sciences
Last Price:
45.70
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereUsana Health Sciences Price Quote
$45.70
-1.40 (-2.97%)
(Updated: May 3, 2024 at 11:15 AM ET)
Usana Health Sciences Key Stats
Buy
52
Usana Health Sciences (USNA)
is a Buy
Day range:
$45.74 - $47.43
52-week range:
$41.45 - $69.60
Dividend yield:
0%
P/E ratio:
14.27
P/S ratio:
1.01
P/B ratio:
1.81%
Volume:
105.3K
Avg. volume:
84.6K
1-year change:
-29.95%
Market cap:
$906.2M
Revenue:
$921M
EPS:
$3.21
How Much Does Usana Health Sciences Make?
-
How Much Are Usana Health Sciences's Sales Annually?
USNA Revenues are $921M -
How Much Profit Does Usana Health Sciences's Make A Year?
USNA net income is $63.8M
Is Usana Health Sciences Growing As A Company?
-
What Is Usana Health Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.08% -
What Is Usana Health Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.09%
Usana Health Sciences Stock Price Performance
-
Did Usana Health Sciences Stock Go Up Last Month?
Usana Health Sciences share price went up by 0.99% last month -
Did USNA's Share Price Rise Over The Last Year?
USNA share price fell by -29.95% over the past 1 year
What Is Usana Health Sciences 52-Week High & Low?
-
What Is Usana Health Sciences’s 52-Week High Share Price?
Usana Health Sciences has traded as high as $69.60 over the past 52 weeks -
What Is Usana Health Sciences’s 52-Week Low Share Price?
Usana Health Sciences has traded as low as $41.45 over the past 52 weeks
Usana Health Sciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Usana Health Sciences?
-
How Much Debt Does Usana Health Sciences Have?
Total long term debt quarterly is $1.3M -
How Much Cash Does Usana Health Sciences Have?
Cash and short term investments quarterly total is $328.3M -
What Is Usana Health Sciences’s Book Value Per Share?
Book value per share is 25.99
Is Usana Health Sciences Cash Flow Positive?
-
What Is USNA Cash Flow From Operations?
Cash flow from operations (TTM) is $70.6M -
What Is Usana Health Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$14.2M -
What Is Usana Health Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$12M
Usana Health Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
USNA return on invested capital is 12.94% -
What Is Usana Health Sciences Return On Assets?
ROA measures how assets are converting to revenues and is 10.08% -
What Is USNA Return On Equity?
ROE is a measure of profitability and is 12.95%
Usana Health Sciences Earnings Date & Stock Price
-
What Is Usana Health Sciences's Stock Price Today?
A single share of USNA can be purchased today for 47.10 -
What Is Usana Health Sciences’s Stock Symbol?
Usana Health Sciences trades on the nyse under the ticker symbol: USNA -
When Is Usana Health Sciences’s Next Earnings Date?
The next quarterly earnings date for Usana Health Sciences is scheduled on July 26, 2024 -
When Is USNA's next ex-dividend date?
Usana Health Sciences's next ex-dividend date is May 1, 2020 -
How To Buy Usana Health Sciences Stock?
You can buy Usana Health Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Usana Health Sciences Competitors
-
Who Are Usana Health Sciences's Competitors?
Below is a list of companies who compete with Usana Health Sciences or are related in some way:
Usana Health Sciences Dividend Yield
Data Unavailable
Usana Health Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -9.47% | 24.64% |
Revenue: | -8.28% | 0.43% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 56.50 |
Upside from Last Price: | 19.96% |